BCM
CDMO

Brookstone Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Brookstone Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-571
Closed -$5K – 2170
2015
Q2 		$5K Buy
+571
New +$5.49K ﹤0.01% 1507

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brookstone Capital Management's CDMO Position: Q3 2015 in Review

Brookstone Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2015, closing a stake of 571 shares — an estimated $5K sold.

Brookstone Capital Management first reported a position in CDMO in Q2 2015 and held it in 1 quarter. The position peaked at $5K in Q2 2015. 83 funds tracked by Wall St. Rank hold CDMO as of Q3 2015.

  • Brookstone Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 571 Avid Bioservices, Inc. Common Stock shares in Q3 2015, an estimated $5K.
  • Brookstone Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Brookstone Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $5K in Q2 2015.
  • 83 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2015.

Based on Brookstone Capital Management's 13F filing for Q3 2015, filed 28 Oct 2015.